language_icon
EN
HI

Sai Life Sciences Share price

SAILIFE

1128.3

16.90 (-1.48%)
NSE
BSE
Last updated on 2 Jun, 2026 | 15:44 IST
Today's High

1144.50

Today's Low

1116.70

52 Week Low

707.00

52 Week High

1184.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sai Life Sciences Chart

Sai Life Sciences Share Key Metrics

Volume
2.96 L
Market Cap
23893.80 CR
LTQ@LTP
10@1128.30
ATP
1131.6
Var Margin
17.89 %
Circuit Range
916.2-1374.2
Delivery %
53.5 %
Value
33.48 CR
ASM/GSM
No
Market Lot
1

Summary

Sai Life Sciences share price is ₹1128.3 as of 2 Jun, 2026. The stock Sai Life Sciences intraday movement has stayed between ₹1116.70 and ₹1144.50, while on a 52-week basis,Sai Life Sciences price 52 week high is ₹1184.80 & its 52 week low is ₹707.00.
In terms of trading activity, Sai Life Sciences has recorded a volume of 295840 shares, The Sai Life Sciences has a market cap of ₹211768134 CR. The stock’s Average Traded Price (ATP) stands at ₹1131.60, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹1128.30.
Sai Life Sciences operates within a circuit range of ₹916.20 – ₹1374.20, with a Value of ₹33.48 CR. The Delivery Percentage for the day is 53.5%. Additionally, Sai Life Sciences currently falls under the No framework, and trades with a market lot size of 1.

Sai Life Sciences Fundamentals

View More
P/E Ratio

70.54

P/B Ratio

9.91

Div. Yield

0

Sector P/E

69.53

Sector P/B

2.99

Sec. Div. Yield

0.55

Sai Life Sciences Resistance and Support

Pivot 1149.3

Resistance

First Resistance

1171.5

Second Resistance

1197.8

Third Resistance

1220

Support

First Support

1123

Second Support

1100.8

Third Support

1074.5

Sai Life Sciences Shareholding Pattern

View More
  • 2026-27
  • 2025-26
  • 2024-25
Total Promoters
Segment
Percent

Total Promoters

34.7%

Mutual Fund

27.57%

Insurance

3.24%

Foreign Institutional Investors

21.41%

Domestic Institutional Investors

0.59%

Retail

12.49%

Others

0%

Total Promoters
MAR '25
35.17%
JUN '25
35.15%
SEP '25
34.94%
DEC '25
34.7%

Sai Life Sciences Corporate Actions

DateAgenda
2026-05-14Audited Results
2026-02-05Quarterly Results
2025-11-06Quarterly Results
2025-08-07Quarterly Results
2025-05-13Audited Results
2025-02-06Quarterly Results

Sai Life Sciences News

Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Sai Life Sciences has made available the recording of its earnings call for the audited financial results of the quarter and year ended March 31, 2026. Investors can access the recording on the company's website.
May 15 2026 19:14:23

Stock Crash: Outperforming contract research firm tanks 14% after Q4 results

Sai Life Sciences' stock experienced a notable decline following its Q4 FY26 earnings release, despite the company's strong performance since its IPO. The market reacted negatively to the reported quarterly results, with the share price falling by approximately 8%.
May 15 2026 10:21:28

Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sai Life Sciences announced audited financial results for FY26, with revenue from operations increasing 29% YoY to Rs.2,192 crore and net profit growing 109% YoY to Rs.355 crore. EBITDA also rose 56% to Rs.661 crore, driven by deepening engagement with large pharma and investments in new technologies.
May 14 2026 23:26:34

Sai Life Sciences Ltd - 544306 - Board Meeting Outcome for Board Meeting Outcome For Approval Of Audited Financial Results For The Financial Year Ending 31.03.2026

Sai Life Sciences' board approved audited Standalone and Cons. Financial Results for Q4 and FY26. For FY26, cons. revenue grew by 29.38% to ₹2,192.49 crores, and net profit increased by 105.07% to ₹348.91 crores. The statutory auditors, Deloitte Haskins & Sells LLP, issued an unmodified opinion on the results.
May 14 2026 22:55:28

Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sai Life Sciences announced its Bidar campus (API manufacturing) is now 100% powered by renewable energy. This makes it the first Indian CRDMO site to achieve full green electricity usage, significantly contributing to the company's sustainability goals by avoiding 35,110 tonnes of CO2 annually.
May 11 2026 16:50:18

Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Sai Life Sciences will host an earnings conference call on May 15, 2026, at 4:00 PM IST to discuss its audited financial results for Q4 FY26 and the full fiscal year. Key management, including the MD & CEO and CFO, will participate.
May 11 2026 11:29:18
Read More

Sai Life Sciences Management

NamePosition
Runa KaranCompany Secretary & Compliance Officer
Kanumuri Ranga RajuChairman
View More

Sai Life Sciences FAQs

The Buying Price of Sai Life Sciences share is 1128.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sai Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sai Life Sciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sai Life Sciences shares is 70.54. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sai Life Sciences shares is 9.91. Useful to assess the stock's value relative to its book value.

To assess Sai Life Sciences’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sai Life Sciences is 23893.80 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sai Life Sciences share price is 1184.80 & 707.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sai Life Sciences belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost